Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Jianhui Nie"'
Autor:
Troy J. Kemp, Gitika Panicker, Carina Eklund, Jianhui Nie, Youchun Wang, Simon Beddows, Peter Rigsby, Weijin Huang, Joakim Dillner, Elizabeth R. Unger, Ligia A. Pinto, Dianna E. Wilkinson, the collaborative study participants
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-13 (2024)
Abstract Previously established World Health Organization (WHO) International Standards (IS) for anti-HPV16 and HPV18 antibodies are used to harmonize results across human papillomavirus (HPV) serology assays. Here, we present an international collab
Externí odkaz:
https://doaj.org/article/e201854fbfbd4a968278b8900d9ad6fb
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTTo summarize the distribution of types of human papillomavirus (HPV) associated with HPV-related diseases and investigate the potential causes of high prevalence of HPV 52 and 58 by summarizing the prevalence of lineages, sub-lineages, and mu
Externí odkaz:
https://doaj.org/article/bedeb5c84f554891b568fa0ea7d409a5
Autor:
Shuo Liu, Li Zhang, Wangjun Fu, Ziteng Liang, Yuanling Yu, Tao Li, Jincheng Tong, Fan Liu, Jianhui Nie, Qiong Lu, Shuaiyao Lu, Weijin Huang, Youchun Wang
Publikováno v:
MedComm, Vol 5, Iss 6, Pp n/a-n/a (2024)
Abstract Spike‐protein‐based pseudotyped viruses were used to evaluate vaccines during the COVID‐19 pandemic. However, they cannot be used to evaluate the envelope (E), membrane (M), and nucleocapsid (N) proteins. The first generation of virus
Externí odkaz:
https://doaj.org/article/c25f891a58b640f9883f7220fd6dd4f6
Autor:
Zehua Zhou, Xinyu Zhang, Meiyu Wang, Fei Jiang, Jincheng Tong, Jianhui Nie, Chenyan Zhao, Haifa Zheng, Zhen Zhang, Penghui Shi, Weiguang Fan, Youchun Wang, Weijin Huang
Publikováno v:
iScience, Vol 27, Iss 6, Pp 109941- (2024)
Summary: The intact proviral DNA assay (IPDA) based on droplet digital PCR was developed to identify intact proviral DNA and quantify HIV-1 latency reservoirs in patients infected with HIV-1. However, the genetic characteristics of different HIV-1 su
Externí odkaz:
https://doaj.org/article/ca9e3a45972b456eaebc86ff1e517482
Autor:
Ziteng Liang, Jincheng Tong, Xi Wu, Shuo Liu, Jiajing Wu, Yuanling Yu, Li Zhang, Chenyan Zhao, Qiong Lu, Jianhui Nie, Weijin Huang, Youchun Wang
Publikováno v:
MedComm, Vol 5, Iss 4, Pp n/a-n/a (2024)
Abstract Regarding the extensive global attention to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that constitutes an international public health emergency, pseudovirus neutralization assays have been widely applied due to their a
Externí odkaz:
https://doaj.org/article/c6d9bfe64b1f457bb3907a4b3d1582ed
Autor:
Qiong Lu, Hao Wu, Jing Meng, Jiangyuan Wang, Jiajing Wu, Shuo Liu, Jincheng Tong, Jianhui Nie, Weijin Huang
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
IntroductionHepatitis E virus (HEV), with heightened virulence in immunocompromised individuals and pregnant women, is a pervasive threat in developing countries. A globaly available vaccine against HEV is currently lacking.MethodsWe designed a multi
Externí odkaz:
https://doaj.org/article/f16484c7d3094af2af60a8c1f58ab507
Autor:
Ziteng Liang, Xi Wu, Jiajing Wu, Shuo Liu, Jincheng Tong, Tao Li, Yuanling Yu, Li Zhang, Chenyan Zhao, Qiong Lu, Haiyang Qin, Jianhui Nie, Weijin Huang, Youchun Wang
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 2 (2023)
The global outbreak of COVID-19 has caused a severe threat to human health; therefore, simple, high-throughput neutralization assays are desirable for developing vaccines and drugs against COVID-19. In this study, a high-titre SARS-CoV-2 pseudovirus
Externí odkaz:
https://doaj.org/article/a18edf92a2004e7184b7de3511f620fb
Autor:
Shuo Liu, Ziteng Liang, Jianhui Nie, Wei bo Gao, Xinyi Li, Li Zhang, Yuanling Yu, Youchun Wang, Weijin Huang
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 2 (2023)
From December 2022 to January 2023, SARS-CoV-2 infections caused by BA.5 and BF.7 subvariants of B.1.1.529 (Omicron) spread in China. It is urgently needed to evaluate the protective immune responses in the infected individuals against the current ci
Externí odkaz:
https://doaj.org/article/399c70797b084abca6f53d659c6e15db
Publikováno v:
Vaccines, Vol 12, Iss 5, p 554 (2024)
Since the emergence of COVID-19, extensive research efforts have been undertaken to accelerate the development of multiple types of vaccines to combat the pandemic. These include inactivated, recombinant subunit, viral vector, and nucleic acid vaccin
Externí odkaz:
https://doaj.org/article/09b15c3852a0449aaeb32aeb36b91560
Autor:
Xingxing Li, Ling Wang, Jingjing Liu, Enyue Fang, Xiaohui Liu, Qinhua Peng, Zelun Zhang, Miao Li, Xinyu Liu, Xiaohong Wu, Danhua Zhao, Lihong Yang, Jia Li, Shouchun Cao, Yanqiu Huang, Leitai Shi, Hongshan Xu, Yunpeng Wang, Yue Suo, Guangzhi Yue, Jianhui Nie, Weijin Huang, Wenjuan Li, Yuhua Li
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 1890-1899 (2022)
The efficacy of many coronavirus disease 2019 (COVID-19) vaccines has been shown to decrease to varying extents against new severe acute respiratory syndrome coronavirus 2 variants, which are responsible for the continuing COVID-19 pandemic. Combinin
Externí odkaz:
https://doaj.org/article/6151175f07c9439393adbd604c8cf68d